Anyang Tumor Hospital
22
5
5
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 22 trials
100.0%
+13.5% vs industry average
45%
10 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (22)
Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer
Role: collaborator
Efficacy Study of Digoxin Combined With Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal Cancer
Role: collaborator
A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC
Role: collaborator
Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer
Role: collaborator
PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer
Role: collaborator
Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy
Role: collaborator
Everolimus Combined With PD-1 in Advanced Colorectal Cancer Patients
Role: collaborator
Sintilimab Plus NCT or NCRT Versus NCRT for ESCC
Role: collaborator
Multi-center Study of Deep Learning AI in Breast Mass
Role: collaborator
Anlotinib for Esophageal Cancer (AFEC)
Role: lead
The Efficacy and Safety of Caffeic Acid for Esophageal Cancer
Role: collaborator
Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01
Role: collaborator
Novel Treatment of Advanced Hepatocellular Carcinoma
Role: collaborator
Treatment of Advanced Intrahepatic Cholangiocarcinoma
Role: collaborator
Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02
Role: collaborator
Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01
Role: collaborator
Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients
Role: collaborator
Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer
Role: collaborator
Treatment of Intermediate-stage Hepatocellular Carcinoma
Role: collaborator
Treatment of Advanced Hepatocellular Carcinoma
Role: collaborator